Selective targeting of microglia by quantum dots

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Minami, S Sakura ^a,b   Sun, Binggui ^a,b   Popat, Ketul ^c,e   Kauppinen, Tiina ^b   Pleiss, Mike ^a   Zhou, Yungui ^a   Ward, Michael E ^a,b   Floreancig, Paul ^d   Mucke, Lennart ^a,b   Desai, Tejal ^c   Gan, Li ^a,b  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e Department of Chemical and Biological Engineering and School of Biomedical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CD11B ANTIGEN; CLATHRIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICROTUBULE ASSOCIATED PROTEIN 2; NEUTRALIZING ANTIBODY; QUANTUM DOT; RIBOSOME INACTIVATING PROTEIN; SAPORIN; SCAVENGER RECEPTOR A; TUMOR NECROSIS FACTOR ALPHA; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); CALCIUM BINDING PROTEIN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; IMMUNOTOXIN; MANNAN; MICROTUBULE ASSOCIATED PROTEIN; PEPTIDE FRAGMENT; POLYINOSINIC ACID; RIBOSOME INACTIVATING PROTEIN 1;

ACIDIFICATION; ACTIN FILAMENT; ARTICLE; CELL CULTURE; CELL FUNCTION; DEPOLYMERIZATION; DOSE RESPONSE; ENDOCYTOSIS; ENDOSOME; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PH; PROTEIN LOCALIZATION; STEREOTACTIC PROCEDURE; SYNAPSE VESICLE; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; BRAIN CORTEX; CELL DEATH; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; NERVE CELL; NEWBORN; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME; TRANSGENIC MOUSE;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CALCIUM-BINDING PROTEINS; CELL DEATH; CEREBRAL CORTEX; CLATHRIN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; IMMUNOTOXINS; MANNANS; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MICROGLIA; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; PEPTIDE FRAGMENTS; POLY I; QUANTUM DOTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; RIBOSOME INACTIVATING PROTEINS, TYPE 1; STEREOTAXIC TECHNIQUES; TIME FACTORS;

EID: 84856069789     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-22     Document Type: Article

References (48)

1. Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG. Does neuroinflammation fan the flame in neurodegenerative diseases?. Mol Neurodegener 2009, 4:47. 10.1186/1750-1326-4-47, 2784760, 19917131.
2. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418. 10.1007/s11481-009-9164-4, 2773116, 19655259.
3. Akiyama H, McGeer PL. Brain microglia constitutively express β-2 integrins. J Neuroimmunol 1990, 30:81-93. 10.1016/0165-5728(90)90055-R, 1977769.
4. Town T, Nikolic V, Tan J. The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation 2005, 2:24. 10.1186/1742-2094-2-24, 1298325, 16259628.
5. Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122. 10.1016/j.neuron.2009.08.039, 2834890, 19840553.
6. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69. 10.1038/nrn2038, 17180163.
7. Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T, Hoenow K, Hu K, Johnson-Wood K, et al. Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci USA 2003, 100:2023-2028. 10.1073/pnas.0436286100, 149952, 12566568.
8. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease--a double-edged sword. Neuron 2002, 35:419-432. 10.1016/S0896-6273(02)00794-8, 12165466.
9. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L. SIRT1 Protects against Microglia-dependent Amyloid-{beta} Toxicity through Inhibiting NF-{kappa}B Signaling. J Biol Chem 2005, 280:40364-40374. 10.1074/jbc.M509329200, 16183991.
10. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544. 10.1126/science.1104274, 1201471, 15681376.
11. Du W, Wang Y, Luo Q, Liu BF. Optical molecular imaging for systems biology: from molecule to organism. Anal Bioanal Chem 2006, 386:444-457. 10.1007/s00216-006-0541-z, 1592253, 16850295.
12. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular probes. Annu Rev Biomed Eng 2005, 7:55-76. 10.1146/annurev.bioeng.7.060804.100432, 16004566.
13. Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013-2016.
14. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976. 10.1038/nbt994, 15258594.
15. Azzazy HM, Mansour MM, Kazmierczak SC. From diagnostics to therapy: prospects of quantum dots. Clin Biochem 2007, 40:917-927. 10.1016/j.clinbiochem.2007.05.018, 17689518.
16. Jaiswal JK, Simon SM. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol 2004, 14:497-504. 10.1016/j.tcb.2004.07.012, 15350978.
17. Vu TQ, Maddipati R, Blute TA, Nehilla BJ, Nusblat L, Desai TA. Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. Nano Lett 2005, 5:603-607. 10.1021/nl047977c, 15826094.
18. Delehanty JB, Mattoussi H, Medintz IL. Delivering quantum dots into cells: strategies, progress and remaining issues. Anal Bioanal Chem 2009, 393:1091-1105. 10.1007/s00216-008-2410-4, 18836855.
19. Jackson H, Muhammad O, Daneshvar H, Nelms J, Popescu A, Vogelbaum MA, Bruchez M, Toms SA. Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas. Neurosurgery 2007, 60:524-529. discussion 529-530.
20. Kauppinen TM, Swanson RA. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol 2005, 174:2288-2296.
21. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85. 10.1016/0003-2697(85)90442-7, 3843705.
22. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem 2009, 78:857-902. 10.1146/annurev.biochem.78.081307.110540, 19317650.
23. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993, 123:1107-1117. 10.1083/jcb.123.5.1107, 2119875, 8245121.
24. Sampath P, Pollard TD. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry 1991, 30:1973-1980. 10.1021/bi00221a034, 1899622.
25. Yarar D, Waterman-Storer CM, Schmid SL. A dynamic actin cytoskeleton functions at multiple stages of clathrin-mediated endocytosis. Mol Biol Cell 2005, 16:964-975. 545926, 15601897.
26. Hussain KM, Leong KL, Ng MM, Chu JJ. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem 2011, 286:309-321. 10.1074/jbc.M110.168468, 3012988, 20956521.
27. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994, 63:601-637. 10.1146/annurev.bi.63.070194.003125, 7979249.
28. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009, 87:181-194. 10.1016/j.pneurobio.2009.01.001, 19388207.
29. Yang CN, Shiao YJ, Shie FS, Guo BS, Chen PH, Cho CY, Chen YJ, Huang FL, Tsay HJ. Mechanism mediating oligomeric Abeta clearance by naive primary microglia. Neurobiol Dis 2011, 42:221-230. 10.1016/j.nbd.2011.01.005, 21220023.
30. Marzolo MP, von Bernhardi R, Inestrosa NC. Mannose receptor is present in a functional state in rat microglial cells. J Neurosci Res 1999, 58:387-395. 10.1002/(SICI)1097-4547(19991101)58:3<387::AID-JNR4>3.0.CO;2-L, 10518112.
31. Meda L, Baron P, Prat E, Scarpini E, Scarlato G, Cassatella MA, Rossi F. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol 1999, 93:45-52. 10.1016/S0165-5728(98)00188-X, 10378868.
32. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 1996, 382:716-719. 10.1038/382716a0, 8751442.
33. Heldmann U, Mine Y, Kokaia Z, Ekdahl CT, Lindvall O. Selective depletion of Mac-1-expressing microglia in rat subventricular zone does not alter neurogenic response early after stroke. Exp Neurol 2011, 229:391-398. 10.1016/j.expneurol.2011.03.005, 21419118.
34. Montero M, Gonzalez B, Zimmer J. Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration. Brain Res 2009, 1291:140-152.
35. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 2009, 29:4252-4262. 10.1523/JNEUROSCI.5572-08.2009, 3034143, 19339619.
36. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392. 10.1126/science.1123511, 16741123.
37. Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 2010, 69:1017-1033. 10.1097/NEN.0b013e3181f3a5b1, 20838243.
38. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010, 37:510-518. 10.1016/j.nbd.2009.11.004, 2823829, 19913097.
39. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010, 42:781-785. 10.1038/ng.642, 2930111, 20711177.
40. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114:165-172. 10.1289/ehp.8284, 1367826, 16451849.
41. Zhang T, Stilwell JL, Gerion D, Ding L, Elboudwarej O, Cooke PA, Gray JW, Alivisatos AP, Chen FF. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett 2006, 6:800-808. 10.1021/nl0603350, 2730586, 16608287.
42. Clift MJ, Rothen-Rutishauser B, Brown DM, Duffin R, Donaldson K, Proudfoot L, Guy K, Stone V. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol 2008, 232:418-427. 10.1016/j.taap.2008.06.009, 18708083.
43. Clift MJ, Varet J, Hankin SM, Brownlee B, Davidson AM, Brandenberger C, Rothen-Rutishauser B, Brown DM, Stone V. Quantum dot cytotoxicity in vitro: An investigation into the cytotoxic effects of a series of different surface chemistries and their core/shell materials. Nanotoxicology 2011, 5:664-74. 10.3109/17435390.2010.534196, 21105833.
44. Seleverstov O, Phang JM, Zabirnyk O. Semiconductor nanocrystals in autophagy research: methodology improvement at nanosized scale. Methods Enzymol 2009, 452:277-296.
45. Seleverstov O, Zabirnyk O, Zscharnack M, Bulavina L, Nowicki M, Heinrich JM, Yezhelyev M, Emmrich F, O'Regan R, Bader A. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett 2006, 6:2826-2832. 10.1021/nl0619711, 17163713.
46. Stern ST, Zolnik BS, McLeland CB, Clogston J, Zheng J, McNeil SE. Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?. Toxicol Sci 2008, 106:140-152. 10.1093/toxsci/kfn137, 2563140, 18632727.
47. Zabirnyk O, Yezhelyev M, Seleverstov O. Nanoparticles as a novel class of autophagy activators. Autophagy 2007, 3:278-281.
48. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939. 10.1016/j.cell.2005.07.002, 16179260.